268 related articles for article (PubMed ID: 30956264)
1. Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
Jiang W; Chen M; Xiao C; Yang W; Qin Q; Tan Q; Liang Z; Liao X; Mao A; Wei C
Biol Pharm Bull; 2019 Jun; 42(6):892-899. PubMed ID: 30956264
[TBL] [Abstract][Full Text] [Related]
2. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
3. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling.
Wang H; Ma D; Wang C; Zhao S; Liu C
Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780
[TBL] [Abstract][Full Text] [Related]
4. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T
Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788
[TBL] [Abstract][Full Text] [Related]
5. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
6. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.
Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L
Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527
[TBL] [Abstract][Full Text] [Related]
7. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
[TBL] [Abstract][Full Text] [Related]
8. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
9. Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.
Park B; Sung B; Yadav VR; Chaturvedi MM; Aggarwal BB
Biochem Pharmacol; 2011 Nov; 82(9):1134-44. PubMed ID: 21820422
[TBL] [Abstract][Full Text] [Related]
10. A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer.
Tian Q; Zhang P; Wang Y; Si Y; Yin D; Weber CR; Fishel ML; Pollok KE; Qiu B; Xiao F; Chong AS
Elife; 2023 Oct; 12():. PubMed ID: 37877568
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the migration and invasion is mediated by triptolide in B16F10 mouse melanoma cells through the NF-kappaB-dependent pathway.
Jao HY; Yu FS; Yu CS; Chang SJ; Liu KC; Liao CL; Ji BC; Bau DT; Chung JG
Environ Toxicol; 2016 Dec; 31(12):1974-1984. PubMed ID: 26420756
[TBL] [Abstract][Full Text] [Related]
12. NF-κB signaling inhibition and anticancer activities of LLDT-246 on human colorectal cancer HCT-116 cells in vitro.
Li M; Wang X; Liu M; Qi X; Li J
Biomed Pharmacother; 2014 Jun; 68(5):527-35. PubMed ID: 24986326
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology of triptolide in cancer cells: implications for transcription factor binding.
Seo EJ; Dawood M; Hult AK; Olsson ML; Efferth T
Invest New Drugs; 2021 Dec; 39(6):1523-1537. PubMed ID: 34213719
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
Zhang J; Zhu JS; Zhou Z; Chen WX; Chen NW
Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223
[TBL] [Abstract][Full Text] [Related]
16. Triptolide-induced in vitro and in vivo cytotoxicity in human breast cancer stem cells and primary breast cancer cells.
Li J; Liu R; Yang Y; Huang Y; Li X; Liu R; Shen X
Oncol Rep; 2014 May; 31(5):2181-6. PubMed ID: 24676587
[TBL] [Abstract][Full Text] [Related]
17. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
[TBL] [Abstract][Full Text] [Related]
19. Antitumor properties of triptolide: phenotype regulation of macrophage differentiation.
Li H; Li L; Mei H; Pan G; Wang X; Huang X; Wang T; Jiang Z; Zhang L; Sun L
Cancer Biol Ther; 2020; 21(2):178-188. PubMed ID: 31663424
[TBL] [Abstract][Full Text] [Related]
20. Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway.
Wan Q; Liu Z; Yang M; Deng P; Tang N; Liu Y
BMC Mol Cell Biol; 2020 Feb; 21(1):4. PubMed ID: 32013860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
